SIRT1 and diabetes mellitus: In contrast, inducible podocyte-specific SIRT1 overexpression in type 1 diabetic OVE26 mice attenuated the progression of diabetic glomerulopathy by reducing albuminuria and attenuating diabetes-induced podocyte loss and oxidative stress.